Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my priority is to protect the patients, the company’s long-term viability, and my own ethical integrity. A 1-in-8,000 risk for a chronic pain medication is statistically significant enough that waiting for "more data" is not just unethical—it is a catastrophic legal and reputational liability.Read the full answer
As CEO, my fundamental leadership principle in a crisis of this magnitude is: You cannot manage a crisis until you accept the full cost of doing the right thing. A safety issue of 1 in 8,000 patients over 5 years across a 4-million-patient population represents approximately 500 potential cases of liver failure.Read the full answer